Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticosteroid replacement in critically ill patients.

Judith Jacobi1

  • 1Pharmacy Department Methodist Hospital/Clarian Health Partners, AG401, 1701 North Senate Boulevard, Indianapolis, IN 46202, USA. jjacobi@clarian.org

Critical Care Clinics
|May 9, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Intensive Versus Conventional Glycemic Control Targets: An Updated Systematic Review and Meta-Analysis of the 2024 Society of Critical Care Medicine Guidelines on Glycemic Control for Critically Ill Adults.

Critical care medicine·2026
Same author

Rethink, Relearn, Repeat. Many Things I Thought I Knew-but Didn't.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

The Sepsis Chain of Survival: A Comprehensive Framework for Improving Sepsis Outcomes.

Critical care medicine·2025
Same author

Society of Critical Care Medicine Guidelines on Glycemic Control for Critically Ill Children and Adults 2024: Executive Summary.

Critical care medicine·2024
Same author

Society of Critical Care Medicine Guidelines on Glycemic Control for Critically Ill Children and Adults 2024.

Critical care medicine·2024
Same author

Flow-Sizing Critical Care Resources.

Critical care medicine·2023

Low-dose corticosteroid replacement therapy in critically ill patients with septic shock improves outcomes. This treatment reduces vasopressor dependence, shortens intensive care unit stays, and lowers mortality rates.

Area of Science:

  • Critical Care Medicine
  • Endocrinology
  • Pharmacology

Background:

  • Septic shock is a life-threatening condition requiring intensive management.
  • Corticosteroid replacement therapy is increasingly considered for specific patient populations.
  • Evidence suggests potential benefits in hemodynamic support and organ function.

Purpose of the Study:

  • To review the current evidence on corticosteroid replacement in critically ill patients.
  • To evaluate the efficacy and safety of low-dose corticosteroids in septic shock.
  • To identify remaining uncertainties regarding patient selection and diagnostic testing.

Main Methods:

  • Systematic review of recent clinical trials and observational studies.
  • Analysis of data on vasopressor use, intensive care unit (ICU) length of stay, and mortality.

Related Experiment Videos

  • Evaluation of different diagnostic approaches for adrenal insufficiency.

    • Main Results:

    • Low-dose corticosteroid therapy significantly reduces the duration of vasopressor-dependent shock.
    • Patients receiving corticosteroid replacement show a shorter ICU length of stay.
    • Recent trials indicate a reduction in mortality among treated patients.

    Conclusions:

    • Corticosteroid replacement is a valuable therapeutic option for select critically ill patients with septic shock.
    • Further research is needed to optimize patient selection and standardize diagnostic testing methods.
    • Optimal interpretation of corticotropin-stimulation tests requires further clarification.